Free Trial
NYSE:OSCR

Oscar Health (OSCR) Stock Price, News & Analysis

Oscar Health logo
$13.41 -0.46 (-3.32%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$13.50 +0.08 (+0.63%)
As of 07/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Oscar Health Stock (NYSE:OSCR)

Key Stats

Today's Range
$13.05
$13.97
50-Day Range
$13.41
$21.53
52-Week Range
$11.20
$23.79
Volume
65.07 million shs
Average Volume
7.77 million shs
Market Capitalization
$3.42 billion
P/E Ratio
47.89
Dividend Yield
N/A
Price Target
$12.92
Consensus Rating
Strong Sell

Company Overview

Oscar Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
43rd Percentile Overall Score

OSCR MarketRank™: 

Oscar Health scored higher than 43% of companies evaluated by MarketBeat, and ranked 665th out of 933 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Oscar Health has received a consensus rating of Strong Sell. The company's average rating score is 1.29, and is based on no buy ratings, 2 hold ratings, and 5 sell ratings.

  • Amount of Analyst Coverage

    Oscar Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Oscar Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Oscar Health are expected to grow by 7.25% in the coming year, from $0.69 to $0.74 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Oscar Health is 47.89, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.53.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Oscar Health is 47.89, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 19.17.

  • Price to Book Value per Share Ratio

    Oscar Health has a P/B Ratio of 3.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Oscar Health's valuation and earnings.
  • Percentage of Shares Shorted

    15.87% of the float of Oscar Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Oscar Health has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oscar Health has recently decreased by 3.90%, indicating that investor sentiment is improving.
  • Dividend Yield

    Oscar Health does not currently pay a dividend.

  • Dividend Growth

    Oscar Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    15.87% of the float of Oscar Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Oscar Health has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oscar Health has recently decreased by 3.90%, indicating that investor sentiment is improving.
  • News Sentiment

    Oscar Health has a news sentiment score of -0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Finance companies.
  • News Coverage This Week

    MarketBeat has tracked 18 news articles for Oscar Health this week, compared to 9 articles on an average week.
  • Search Interest

    105 people have searched for OSCR on MarketBeat in the last 30 days. This is an increase of 377% compared to the previous 30 days.
  • MarketBeat Follows

    42 people have added Oscar Health to their MarketBeat watchlist in the last 30 days. This is an increase of 320% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Oscar Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $410,750.00 in company stock.

  • Percentage Held by Insiders

    24.39% of the stock of Oscar Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    75.70% of the stock of Oscar Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Oscar Health's insider trading history.
Receive OSCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oscar Health and its competitors with MarketBeat's FREE daily newsletter.

OSCR Stock News Headlines

Small Caps, Big Opportunities - This image is an original composition by MarketBeat using licensed and editorial elements. Not for redistribution or reuse.
5 Small Cap Stocks With Explosive Upside Potential (OSCR)
Small-cap stocks have been gaining momentum in 2025, with several names showing upside potential driven by improving fundamentals and technical breakouts.
Oscar Health (NYSE:OSCR) Receives "Sell" Rating from UBS Group
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
UBS Downgrades Oscar Health (OSCR)
Oscar Health, Inc. (OSCR): A Bull Case Theory
See More Headlines

OSCR Stock Analysis - Frequently Asked Questions

Oscar Health's stock was trading at $13.44 on January 1st, 2025. Since then, OSCR shares have decreased by 0.2% and is now trading at $13.41.

Oscar Health, Inc. (NYSE:OSCR) announced its quarterly earnings data on Wednesday, May, 7th. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.83 by $0.09. The business's revenue for the quarter was up 42.2% on a year-over-year basis.
Read the conference call transcript
.

Oscar Health (OSCR) raised $1 billion in an initial public offering on Wednesday, March 3rd 2021. The company issued 31,000,000 shares at a price of $32.00-$34.00 per share. Goldman Sachs, Morgan Stanley, Allen & Co., Wells Fargo Securities, BofA Securities and Credit Suisse acted as the underwriters for the IPO and Cowen, Lion Tree, Ramirez & Co. and Siebert Williams Shank were co-managers.

Oscar Health's top institutional shareholders include Assenagon Asset Management S.A. (0.24%), Fiduciary Alliance LLC (0.18%), Halter Ferguson Financial Inc. (0.08%) and Bosman Wealth Management LLC (0.03%). Insiders that own company stock include Joshua Kushner, Thrive Partners Vii Growth Gp,, Richard Scott Blackley, Alessandrea C Quane, Sid Sankaran, Ranmali Bopitiya, Victoria Baltrus, Steven Wolin, Mario Schlosser, Elbert O Jr Robinson and Alphabet Inc.
View institutional ownership trends
.

Shares of OSCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oscar Health investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
5/07/2025
Today
7/19/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Finance
Industry
INS - MULTI LINE
Sub-Industry
Insurance
Current Symbol
NYSE:OSCR
CIK
1568651
Fax
N/A
Employees
2,400
Year Founded
N/A

Price Target and Rating

High Price Target
$17.00
Low Price Target
$10.00
Potential Upside/Downside
-3.7%
Consensus Rating
Strong Sell
Rating Score (0-4)
1.29
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.28
Trailing P/E Ratio
47.89
Forward P/E Ratio
19.43
P/E Growth
N/A
Net Income
$25.43 million
Net Margins
1.22%
Pretax Margin
1.42%
Return on Equity
10.59%
Return on Assets
2.45%

Debt

Debt-to-Equity Ratio
0.22
Current Ratio
0.88
Quick Ratio
0.88

Sales & Book Value

Annual Sales
$9.18 billion
Price / Sales
0.37
Cash Flow
$0.12 per share
Price / Cash Flow
110.41
Book Value
$4.06 per share
Price / Book
3.30

Miscellaneous

Outstanding Shares
254,680,000
Free Float
192,561,000
Market Cap
$3.42 billion
Optionable
Optionable
Beta
1.90
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSE:OSCR) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners